Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database
Sylvie Bonvalot(Dana-Farber Cancer Institute), Jean‐Yves Blay(Université Claude Bernard Lyon 1), Dimitri Tzanis(Université Paris Cité), Françoise Ducimetière(Université Claude Bernard Lyon 1), M. Fau(Biocodex (France)), Gauthier Decanter(Centre Oscar Lambret), Charles Honoré(Institut Gustave Roussy), J. M. Guillois(Centre François Baclesse), Pierre Gimbergues(Centre Jean Perrin), Sylvain Causeret(Champalimaud Foundation), Pierre Méeus(Centre Léon Bérard), Maud Toulmonde(Institut Bergonié), Sébastien Carrère, Eberhard Stoeckle(Institut Bergonié), Axel Le Cesne(Institut Gustave Roussy), Elodie Gaignard(Université Paris Sciences et Lettres), B. Meunier(Hôpital l'Archet), Jean‐Baptiste Delhorme(Hôpitaux Universitaires de Strasbourg)
Cited by 151
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k